CBLN1 and type 2 diabetes mellitus: As such, we selected Cer(d18:1/24:0)/SM(d18:1/19:0) and Cer(d18:1/24:0)/SM(d18:0/16:0) as candidate features for the development of an integrated diagnostic biosignature for prediabetes and T2DM.